Federal Register / Vol. 70, No.
84 / Tuesday, May 3, 2005 / Notices
determined by the Freedom of
Information officials of DHHS or by a
court, data contained in the portions of
an application which have been
specifically identified by page number,
paragraph, etc., by the applicant as
containing restricted and/or proprietary
information shall not be used or
disclosed except for evaluation
purposes.
Dated: April 26, 2005.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 05–8819 Filed 5–2–05; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Pub. L. 92–463, notice is
hereby given of the seventh meeting of
the Secretary’s Advisory Committee on
Genetics, Health, and Society
(SACGHS), U.S. Public Health Service.
The meeting will be held from 8:30 a.m.
to 5:30 p.m. on June 15, 2005 and 8:30
a.m. to 5:30 p.m. on June 16, 2005 at the
Bethesda North Marriott Hotel, 5701
Marinelli Road, North Bethesda,
Maryland. The meeting will be open to
the public with attendance limited to
space available. The meeting will be
Webcast.
The topics of the first day are
expected to be genetic discrimination,
direct-to-consumer marketing of genetic
tests, and coverage and reimbursement
of genetic tests and services. The
Committee aims to finalize a report on
coverage and reimbursement of genetic
tests and services after considering
public comments. The topics for the
second day are expected to include large
population studies of gene-environment
interactions and pharmacogenomics.
Time will be provided each day for
public comments.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the
Webcast, will be available at the
VerDate jul<14>2003 15:43 May 02, 2005 Jkt 205001
22893
following Web site: http://
www4.od.nih.gov/oba/sacghs.htm.
The Committee would welcome
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment or who plan to attend the
meeting and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone
at 301–496–9838 or e-mail at
sc112c@nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892.
LaVerne Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8780 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Directors
Consumer Liaison Group.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Director’s Consumer Liaison Group.
Date: May 26, 2005.
Time: 3 p.m. to 5 p.m.
Agenda: Opening remarks; approval of
minutes February 28–March 1, 2005 DCLG
meeting; NCI Director’s Remarks; reports
from NCI Listens and Learns Working
Groups: Operations Working Group, Summit
Working Group, Promotions Working Group,
and Evaluation Working Group; DCLG
recommendations on the Progress Review
Group Process; public comment; next steps.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Nancy Caliman, Executive
Secretary, Office of Liaison Activities,
National Institutes of Health, National Cancer
Institutes, 6116 Executive Boulevard, Suite
220, MS8324, Bethesda, MD 20892, (301)
496–0307, calimann@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\03MYN1.SGM
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: http://
deainfo.nci.nih.gov/advisory/dclg/dclg.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS.)
Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8779 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel.
Date: May 6, 2005.
Time: 11:30 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Telephone
Conference Call).
Contact Person: Barbara J. Nelson, PhD.,
Scientific Review Administrator, Office of
Review, National Center for Research
Resources, NIH, 6701 Democracy Blvd, Room
1080, 1 Democracy Plaza, Bethesda, MD
20892, (301) 435–0806.
This notice is being published less than 15
days prior to the meeting due to the timing
03MYN1
 22894 Federal Register / Vol. 70, No. 84 / Tuesday, May 3, 2005 / Notices
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333, National Institutes of Health,
HHS).
Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8783 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Initial Review Group, Diabetes,
Endocrinology and Metabolic Diseases B
Subcommittee.
Date: June 7–9, 2005.
Open: June 7, 2005, 6 p.m. to 6:30 p.m.
Agenda: To review procedures and discuss
policies.
Place: Wyndham San Diego at Emerald
Plaza, 400 West Broadway, San Diego, CA
92101.
Closed: June 7, 2005, 6:30 p.m. to 11 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham San Diego at Emerald
Plaza, 400 West Broadway, San Diego, CA
92101.
Closed: June 8, 2005, 8 a.m. to 5 p.m.
VerDate jul<14>2003 15:43 May 02, 2005 Jkt 205001
Agenda: To review and evaluate grant
applications.
Place: Wyndham San Diego at Emerald
Plaza, 400 West Broadway, San Diego, CA
92101.
Closed: June 9, 2005, 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham San Diego at Emerald
Plaza, 400 West Broadway, San Diego, CA
92101.
Contact Person: John F. Connaughton, PhD,
Scientific Review Administrator, Review
Branch, DEA, NIDDK, National Institutes of
Health, Room 757, 6707 Democracy
Boulevard, Bethesda, MD 20892–5452, (301)
594–7797, connaughton@
extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8778 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel, Speech
Processor Optimization for Cochlear
Implants.
Date: May 24, 2005.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 E:\FR\FM\03MYN1.SGM
Contact Person: Da-yu Wu, PhD, Scientific
Review Administrator, Scientific Review
Branch, Division of Extramural Activities,
NIDCD, NIH, 6120 Executive Blvd., Suite
400C, Bethesda, MD 20892, 301–496–8683,
wudy@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communications
Disorders Special Emphasis Panel,
Translational Research Grants.
Date: June 1, 2005.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Stanley C. Oaks, PhD.,
Scientific Review Administrator, Division of
Extramural Activities, NIDCD, NIH,
Executive Plaza South, Room 400C, 6120
Executive Blvd–MSC 7180, Bethesda, MD
20892–7180, 301–496–8683, so14s@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health,
HHS.)
Dated: April 25, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–8782 Filed 5–2–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Special
Emphasis Panel, ZAA1 HH (30) Fellowship
Applications.
Date: May 17, 2005.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
03MYN1